The Longitudinal Parallel Process Analysis of Biomarkers of Oxidative Stress, Symptom Clusters, and Cognitive

Mary C Hooke1,2, Daniel Hatch3, Marilyn J Hockenberry2,4

  • 1University of Minnesota, Minneapolis, MN, USA.

Insights

Children undergoing acute lymphoblastic leukemia (ALL) treatment with lower oxidative stress experienced fewer symptoms and better cognition. Higher glutathione biomarkers, indicating less oxidative stress, correlated with improved outcomes in pediatric leukemia patients.

Area of Science:

  • Pediatric Oncology
  • Neuro-Oncology
  • Translational Medicine

Background:

  • Children with acute lymphoblastic leukemia (ALL) often experience a cluster of symptoms including fatigue, sleep disturbance, pain, nausea, and depression.
  • Central nervous system-directed therapies for ALL increase the risk of cognitive impairments in children.
  • Cancer treatments can elevate oxidative stress, potentially contributing to these treatment-related symptoms and cognitive deficits.

Purpose of the Study:

  • To investigate the longitudinal relationships between cerebrospinal fluid oxidative stress biomarkers, the Childhood Cancer Symptom Cluster-Leukemia (CCSC-L), and cognitive function in children during the first year of ALL treatment.
  • To explore how changes in glutathione (GSH) biomarkers over time influence symptom clusters and cognition.

Main Methods:

  • GSH biomarkers, a measure of oxidative stress, were analyzed in cerebrospinal fluid from 132 children (aged 3-18) with ALL at four time points during the first year of treatment.
  • Symptom severity (CCSC-L) and cognitive function were assessed longitudinally using self-reports (for participants aged 7+) and parent reports.
  • A longitudinal parallel-process model analyzed the impact of initial GSH levels and their changes on CCSC-L and cognition.

Main Results:

  • GSH biomarkers increased over time, signifying a decrease in oxidative stress during the treatment year.
  • Higher initial GSH biomarker levels (indicating less oxidative stress) were associated with lower CCSC-L severity and better cognitive function at baseline.
  • Cognitive function showed improvement over the four measurement time points in relation to GSH levels.

Conclusions:

  • Reduced oxidative stress, as indicated by higher GSH biomarkers, is linked to a less severe symptom cluster and better cognitive function in children undergoing ALL treatment.
  • Monitoring oxidative stress may provide a basis for developing future interventions to mitigate symptom distress and cognitive impairments in pediatric leukemia patients.